Oct 8, 2018 - Energy & Environment

Tesla's former finance chief becomes CFO of genomics startup

Dan Primack, author of Pro Rata

Illustration: Sarah Grillo/Axios

Justin McAnear last month resigned as VP of global finance and operation for Tesla, in order to take a CFO job at an undisclosed company. Now we know his new employer: 10X Genomics, a Silicon Valley genomics company whose investors include Fidelity and SoftBank.

Why it matters: First, because it solves a Silicon Valley mystery. Second, because it may signal IPO plans for 10X Genomics.

10x Genomics CEO Serge Saxonov said the company was already deep in talks with McAnear when Tesla CEO Elon Musk issued his infamous "funding secured" tweet, adding that McAnear "has an awesome mixture of intensity and humility."

Saxonov declined to comment on possible IPO plans, except to give general startup CEO-speak about how "our goal is to build a large, successful company."

Go deeper

Axios
Updated 15 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3:30 p.m. ET: 10,763,604 — Total deaths: 517,667 — Total recoveries — 5,522,094 — Map.
  2. U.S.: Total confirmed cases as of 3:30 p.m. ET: 2,715,124 — Total deaths: 128,439 — Total recoveries: 729,994 — Total tested: 32,827,359 — Map.
  3. Public health: What we know about the immune response to coronavirus and what it means for a vaccine.
  4. Politics: Herman Cain hospitalized for COVID-19 after attending Trump Tulsa rally — Biden downplays jobs number, rebukes Trump for ignoring health crisis.
  5. States: Florida reports more than 10,000 new coronavirus cases — 5 states saw 27% spike in heart-related deaths in first 3 months of coronavirus pandemic.
Go deeper (<1 min. read)Arrow
Alison Snyder, Eileen Drage O'Reilly
21 mins ago - Science

The other immune responders to COVID-19

Illustration: Eniola Odetunde/Axios

Scientists are inching closer to understanding how antibodies and immune cells are unleashed by the body in response to the novel coronavirus.

Why it matters: Natural immunity differs from that afforded by vaccination but it offers clues for the design of effective vaccines and therapies.

Go deeper (3 min. read)Arrow
Felix Salmon
2 hours ago - Health

Cash can't fix the economy's problems until the coronavirus is curbed

Illustration: Sarah Grillo/Axios

There's plenty of money. It's just not moving to where it's needed.

Driving the news: Thursday's jobs report showed 4.8 million jobs created in June, but those were overwhelmingly people beginning to return to places where they had been temporarily laid off. The number of "permanent job losers" went up, not down, rising 25% in just one month to 2.8 million from 2.2 million.

Go deeper (2 min. read)Arrow